Evidence map›Paper›PMID 20148031›Full record

ArticleNature2010

Neural bases for addictive properties of benzodiazepines.

Kelly R Tan, Matthew Brown, Gwenaël Labouèbe, Cédric Yvon, Cyril Creton, Jean-Marc Fritschy, Uwe Rudolph, Christian Lüscher

Open access · greenAbstract read
In one paragraph

Article in Nature, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 185 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
185citing papers in PubMed, 2 pooled it
12.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

185 citing papers in PubMed, 2 syntheses or guidelines pooled it, 392 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Trial
  4. Trial
  5. Herbal triplet in treatment of nervous agitation in children.Wiener medizinische Wochenschrift (1946) · 2013
    Trial
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Kappa Opioid Receptors Control a Stress-Sensitive Brain Circuit and Drive Cocaine Seeking.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  20. Article

125 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Kelly R TanDepartment of Basic Neurosciences, Medical Faculty, University of Geneva, CH-1211 Geneva, Switzerland.
Matthew Brown
Gwenaël Labouèbe
Cédric Yvon
Cyril Creton
Jean-Marc Fritschy
Uwe Rudolph
Christian Lüscher
University of Geneva · CHMcLean Hospital · USUniversity of Zurich · CH

Funding

Kir 3 Channel Subunits in Drug Abuse with GABAB AgonistsR01DA019022 · NIDA · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI SLESINGER, PAUL A · 2006 to 2010
$2.3M
NIDA NIH HHS DA019022NIDA NIH HHS R01 DA019022
6 · The paper itself

Abstract

Benzodiazepines are widely used in clinics and for recreational purposes, but will lead to addiction in vulnerable individuals. Addictive drugs increase the levels of dopamine and also trigger long-lasting synaptic adaptations in the mesolimbic reward system that ultimately may induce the pathological behaviour. The neural basis for the addictive nature of benzodiazepines, however, remains elusive. Here we show that benzodiazepines increase firing of dopamine neurons of the ventral tegmental area through the positive modulation of GABA(A) (gamma-aminobutyric acid type A) receptors in nearby interneurons. Such disinhibition, which relies on alpha1-containing GABA(A) receptors expressed in these cells, triggers drug-evoked synaptic plasticity in excitatory afferents onto dopamine neurons and underlies drug reinforcement. Taken together, our data provide evidence that benzodiazepines share defining pharmacological features of addictive drugs through cell-type-specific expression of alpha1-containing GABA(A) receptors in the ventral tegmental area. The data also indicate that subunit-selective benzodiazepines sparing alpha1 may be devoid of addiction liability.

Indexed as

Action PotentialsAdministration, OralAnimalsBehavior, AddictiveBenzodiazepinesDopamineElectric Conductivitygamma-Aminobutyric AcidGlutamic AcidInhibitory Postsynaptic PotentialsInterneuronsIn Vitro TechniquesMiceMice, Inbred C57BLMidazolamModels, BiologicalBenzodiazepinesDopamineGabra1 protein, mousegamma-Aminobutyric AcidGlutamic AcidMidazolamMorphineReceptors, AMPAReceptors, GABA-A

Identifiers

PMID20148031
PMCPMC2871668
OpenAlexW1973651679

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.